This project has established an anti-tumor drug production workshop, including three workshops: non-sterile raw materials, oral solid preparations (tablets, capsules), injections (non terminally sterilized injections, freeze-dried powder injections), warehousing, QC laboratory systems, and supporting infrastructure. The production technology of anti-tumor drug products, including stability and efficacy, was certified by the European Union in November 2019. Increasing investment in research and development, introducing high-end foreign and domestic experts, developing urgently needed anti-tumor products in the market, and striving to market and sell anti-tumor drugs as soon as possible is one of the new treatment fields that the company plans to focus on. With the increase of tumor incidence rate, its market expansion is accelerating, and it has good growth potential. Its international market share is the largest in the overall drug market, and its domestic market share is second only to anti infective drugs, It will soon become the largest treatment field. Our company has chosen to develop anti-tumor drugs in order to provide high-quality and affordable anti-tumor drugs for our patients. Antitumor drugs are one of the new therapeutic fields that the company plans to focus on. With the increase of the incidence rate of cancer, its market has a good growth potential. The international market has the largest share of the overall drug market, and the domestic market share is second only to anti infective drugs. It will soon become the largest therapeutic field. Our company has chosen to develop anti-tumor drugs in order to provide high-quality and affordable anti-tumor drugs for our patients.